Good point Tanis and thanks. I have went through the message board and done my DD on LymPro. I am hoping Gerald will pull a rabbit out of his hat without the next month or so regarding the test. A serious partnership or data of at least 90% accuracy will be needed for the test to be highly successful, but I guess ANY sort of revenue at all from Lympro will be crucial for a clinical stage company such as AMBS to help fund MANF!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links